{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:44:37Z","timestamp":1754145877089,"version":"3.41.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ekir.2025.03.021","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:16:15Z","timestamp":1742184975000},"page":"1960-1970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nested Case-Control Study of Intervention in Early Infancy to Prevent Tuberous Sclerosis Complex\u2013Associated Renal Angiomyolipoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Shuo","family":"Dun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.03.021_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2025.03.021_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2025.03.021_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ekir.2025.03.021_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1756287216641353","article-title":"Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review","volume":"8","author":"Bissler","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.ekir.2025.03.021_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ndt\/gfy063","article-title":"Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the tuberous sclerosis registry to increase disease awareness","volume":"34","author":"Kingswood","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2025.03.021_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","article-title":"Natural history of renal angiomyolipoma (AML): most patients with large AMLs > 4 cm can be offered active surveillance as an initial management strategy","volume":"70","author":"Bhatt","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ekir.2025.03.021_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41687-018-0055-4","article-title":"Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey","volume":"2","author":"Rentz","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.ekir.2025.03.021_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/13696998.2016.1272461","article-title":"Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma","volume":"20","author":"Song","year":"2017","journal-title":"J Med Econ"},{"key":"10.1016\/j.ekir.2025.03.021_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.03.021_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00313020310001619136","article-title":"Renal pathology in the tuberous sclerosis complex","volume":"35","author":"Martignoni","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.ekir.2025.03.021_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2020.03.018","article-title":"Sirolimus improves seizure control in pediatric patients with tuberous sclerosis: a prospective cohort study","volume":"79","author":"He","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.ekir.2025.03.021_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpeds.2021.02.040","article-title":"Sirolimus can increase the disappearance rate of cardiac rhabdomyomas associated with tuberous sclerosis: a prospective cohort and self-controlled case series study","volume":"233","author":"Chen","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.ekir.2025.03.021_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1750-1172-7-87","article-title":"Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial","volume":"7","author":"Cabrera-L\u00f3pez","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ekir.2025.03.021_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13023-019-1178-2","article-title":"Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis","volume":"14","author":"Hu","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ekir.2025.03.021_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2025.03.021_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12519-023-00751-5","article-title":"Sirolimus can promote the disappearance of renal angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study","volume":"20","author":"Dun","year":"2024","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ekir.2025.03.021_bib17","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2012-3607","article-title":"Possible prevention of tuberous sclerosis complex lesions","volume":"132","author":"Kotulska","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ekir.2025.03.021_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.33.6.480","article-title":"A cross sectional study of renal involvement in tuberous sclerosis","volume":"33","author":"Cook","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.ekir.2025.03.021_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2025.03.021_bib20","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1093\/hmg\/ddr393","article-title":"Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex","volume":"20","author":"Anderl","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ekir.2025.03.021_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ekir.2025.03.021_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40120-023-00476-7","article-title":"Effect of mTOR inhibitors in epilepsy treatment in children with tuberous sclerosis complex under 2 years of age","volume":"12","author":"\u015amia\u0142ek","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ekir.2025.03.021_bib23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","article-title":"Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): multicentre clinical experience","volume":"22","author":"Krueger","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ekir.2025.03.021_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13023-019-1077-6","article-title":"Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age\u2013a multicenter retrospective study","volume":"14","author":"Saffari","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ekir.2025.03.021_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/jcm12010365","article-title":"Safety of sirolimus in patients with tuberous sclerosis complex under two years of age\u2014a bicenter retrospective study","volume":"12","author":"\u015amia\u0142ek","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2025.03.021_bib26","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2025.03.021_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ekir.2025.03.021_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ekir.2025.03.021_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.973845","article-title":"Long-term efficacy and safety of sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ekir.2025.03.021_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13023-021-01932-z","article-title":"Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China","volume":"16","author":"Luo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ekir.2025.03.021_bib31","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study","volume":"11","author":"Tan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2025.03.021_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2016.01.027","article-title":"Safety of everolimus in patients younger than 3 years of age: results from EXIST-1, a randomized, controlled clinical trial","volume":"172","author":"J\u00f3\u017awiak","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.ekir.2025.03.021_bib33","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients","volume":"43","author":"Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ekir.2025.03.021_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13023-024-03243-5","article-title":"Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis","volume":"19","author":"Wang","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ekir.2025.03.021_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00381-022-05446-2","article-title":"Long-term administration of sirolimus does not affect the physical development of children with tuberous sclerosis complex","volume":"38","author":"Chen","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ekir.2025.03.021_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1399-3046.2011.01574.x","article-title":"Linear growth in pediatric renal transplant recipients receiving sirolimus","volume":"15","author":"Hymes","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2025.03.021_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40272-019-00337-7","article-title":"Off-label use of sirolimus and everolimus in a pediatric center: A case series and review of the literature","volume":"21","author":"Bevacqua","year":"2019","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.ekir.2025.03.021_bib38","first-page":"367","article-title":"Experience with the mTOR inhibitor everolimus in pediatric liver graft recipients","volume":"10","author":"Wehming","year":"2023","journal-title":"Children (Basel)"},{"key":"10.1016\/j.ekir.2025.03.021_bib39","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ekir.2025.03.021_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-024-03495-1","volume":"20","author":"Driedger","year":"2025","journal-title":"Orphanet J Rare Dis"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925001640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925001640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:27:27Z","timestamp":1752766047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925001640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2468024925001640"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.03.021","relation":{},"ISSN":["2468-0249"],"issn-type":[{"type":"print","value":"2468-0249"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nested Case-Control Study of Intervention in Early Infancy to Prevent Tuberous Sclerosis Complex\u2013Associated Renal Angiomyolipoma","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}